Nano Mobile Healthcare, Inc. (VNTH)
| Market Cap | 654.75K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -1.47K |
| Shares Out | 3.27B |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,969,998 |
| Average Volume | 3,059,354 |
| Open | 0.0002 |
| Previous Close | 0.0002 |
| Day's Range | 0.0001 - 0.0002 |
| 52-Week Range | 0.0001 - 0.0003 |
| Beta | -0.76 |
| RSI | 48.90 |
| Earnings Date | n/a |
About Nano Mobile Healthcare
Nano Mobile Healthcare, Inc. operates as a mobile health technology company in the United States. The company develops personalized and point-of-care screening using applications based upon chemical sensing methods. It has a strategic partnership with Theranostics Laboratory, a translational research company. The company was formerly known as Vantage mHealthcare, Inc. and changed its name to Nano Mobile Healthcare, Inc. in September 2015. Nano Mobile Healthcare, Inc. was incorporated in 2010 and is based in Boston, Massachusetts. Nano Mobile He... [Read more]
Financial Performance
Financial StatementsNews
Nano Mobile Healthcare, Inc Announces Closing of Change of Control Transaction and Provided Shareholders' Update
LOS ANGELES, CA, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Nano Mobile Healthcare, Inc. “the Company” (OTC: VNTH) is pleased to announce that the closing of the change of control deal announced on September ...